Jazz Pharmaceuticals plc — Director's Dealing 2013

Mar 22, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-03-21

Reporting Person: COZADD BRUCE C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-21	Ordinary Shares	M	15902	$15.09	Acquired	638063	Direct
2013-03-21	Ordinary Shares	M	5299	$30.18	Acquired	643362	Direct
2013-03-21	Ordinary Shares	M	5299	$45.27	Acquired	648661	Direct
2013-03-21	Ordinary Shares	M	12583	$19.37	Acquired	661244	Direct
2013-03-21	Ordinary Shares	M	7040	$7.96	Acquired	668284	Direct
2013-03-21	Ordinary Shares	M	182	$1.25	Acquired	668466	Direct
2013-03-21	Ordinary Shares	M	2177	$11.48	Acquired	670643	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-21	Incentive Stock Option (right to buy)	$15.09	M	15902	Disposed	2014-02-17	Ordinary Shares (15902)	Direct
2013-03-21	Incentive Stock Option (right to buy)	$30.18	M	5299	Disposed	2014-02-17	Ordinary Shares (5299)	Direct
2013-03-21	Incentive Stock Option (right to buy)	$45.27	M	5299	Disposed	2014-02-17	Ordinary Shares (5299)	Direct
2013-03-21	Incentive Stock Option (right to buy)	$19.37	M	12583	Disposed	2017-02-26	Ordinary Shares (12583)	Direct
2013-03-21	Incentive Stock Option (right to buy)	$7.96	M	7040	Disposed	2018-05-15	Ordinary Shares (7040)	Direct
2013-03-21	Incentive Stock Option (right to buy)	$1.25	M	182	Disposed	2019-01-20	Ordinary Shares (182)	Direct
2013-03-21	Incentive Stock Option (right to buy)	$11.48	M	2177	Disposed	2020-03-07	Ordinary Shares (2177)	Direct

Footnotes

F1: This option fully vested on February 18, 2008.

F2: This option fully vested on February 27, 2012.

F3: This option fully vested on April 8, 2012.

F4: This option fully vested on January 21, 2012.

F5: Following the reported transaction, the remaining ordinary shares subject to this option vest with respect to 6,533 shares in nine equal monthly installments from April 8, 2013 to December 8, 2013 and with respect to 8,710 shares in three equal monthly installments from January 8, 2014 to March 8, 2014.